Lois Elaine Hodgson Smith

Title: Lois Elaine Hodgson Smith: Innovator in Neovascularization Treatment

Introduction

Lois Elaine Hodgson Smith is a notable inventor based in West Newton, MA (US). She has made significant contributions to the field of medical science, particularly in the area of neovascularization. Her innovative work has the potential to impact various disorders associated with this condition.

Latest Patents

Lois holds a patent titled "Inhibition of neovascularization using VEGF-specific oligonucleotides." This patent discloses methods for reducing neovascularization and treating disorders linked to it. The methods involve administering a synthetic oligonucleotide specific for vascular endothelial growth factor (VEGF) nucleic acid, which effectively inhibits the expression of VEGF.

Career Highlights

Throughout her career, Lois has worked with prominent organizations, including Hybridon, Inc. and Children's Medical Center Corporation. Her experience in these institutions has allowed her to develop and refine her innovative ideas in the medical field.

Collaborations

Lois has collaborated with various professionals, including her coworker Gregory S. Robinson. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Lois Elaine Hodgson Smith is a pioneering inventor whose work in neovascularization treatment showcases her dedication to improving medical science. Her contributions continue to inspire future innovations in the field.